Skeletal Radiology

, Volume 41, Issue 3, pp 347–352

Imaging of recurrent intramuscular granulomatous masses induced by depot injection of leuprorelin

Authors

    • Division of Musculoskeletal Radiology, Department of RadiologyDuke University Medical Center
  • Andresa Braga-Baiak
    • Sugisawa Medical CenterDepartment of Radiology
  • Leslie G. Dodd
    • Department of PathologyDuke University Medical Center
  • Salutario Martinez
    • Division of Musculoskeletal Radiology, Department of RadiologyDuke University Medical Center
Case Report

DOI: 10.1007/s00256-011-1254-8

Cite this article as:
Vinson, E.N., Braga-Baiak, A., Dodd, L.G. et al. Skeletal Radiol (2012) 41: 347. doi:10.1007/s00256-011-1254-8

Abstract

Leuprorelin is a luteinizing hormone-releasing hormone (LH-RH) agonist that is used as an agent of androgen deprivation in some patients with prostate cancer. When administered in depot form, local granulomatous reactions may occur at the injection site, which may mimic masses and which are associated with treatment failure. We present a patient who, over a period of 5 years, developed multiple intramuscular gluteal masses while receiving leuprorelin therapy via intramuscular depot injections; biopsy of one of the masses showed the specific histologic features of leuprorelin granuloma. To our knowledge, this entity has not been described in the radiology literature. Awareness of this entity is necessary to suggest the correct diagnosis in patients with a history of leuprorelin depot injections.

Keywords

Prostate cancerLeuprorelin (INN)Leuprolide acetate (USAN)Intramuscular granulomaSterile abscessGnRH agonistLH-RH agonistMRIPET

Copyright information

© ISS 2011